RAFAEL HOLDINGS, INC. Costs and Expenses, Related Party
RAFAEL HOLDINGS, INC. (RFL) reported Costs and Expenses, Related Party of $60.00 thousand for the 3-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpensesRelatedParty · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. costs and expenses, related party for the quarter ending 2026-04-30 was $60.00K, a 1.64% decline year-over-year.
- RAFAEL HOLDINGS, INC. costs and expenses, related party for the quarter ending 2026-01-31 was $69.00K, a 18.82% decline year-over-year.
- RAFAEL HOLDINGS, INC. costs and expenses, related party for the quarter ending 2025-10-31 was $88.00K, a 25.71% increase year-over-year.
- RAFAEL HOLDINGS, INC. costs and expenses, related party for the quarter ending 2025-07-31 was $54.00K, a 21.74% decline year-over-year.
- RAFAEL HOLDINGS, INC. costs and expenses, related party for fiscal 2025 was $275.00K, a 7.09% decline from fiscal 2024.
- RAFAEL HOLDINGS, INC. costs and expenses, related party for fiscal 2024 was $296.00K, a 5.43% decline from fiscal 2023.
- RAFAEL HOLDINGS, INC. costs and expenses, related party for fiscal 2023 was $313.00K, a 8.75% decline from fiscal 2022.
- RAFAEL HOLDINGS, INC. costs and expenses, related party for fiscal 2022 was $343.00K.
| Period end | Costs and Expenses, Related Party 3 month | Costs and Expenses, Related Party 6 month | Costs and Expenses, Related Party 9 month | Costs and Expenses, Related Party 12 month |
|---|---|---|---|---|
| 2026-04-30 | $60.00K 10-Q · filed 2026-06-11 | $129.00K derived: sum of 2 quarters · filed 2026-06-11 | $217.00K 10-Q · filed 2026-06-11 | $271.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2026-01-31 | $69.00K 10-Q · filed 2026-03-16 | $157.00K 10-Q · filed 2026-03-16 | $211.00K derived: sum of 3 quarters · filed 2026-03-16 | $272.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-10-31 | $88.00K 10-Q · filed 2025-12-12 | $142.00K derived: sum of 2 quarters · filed 2025-12-12 | $203.00K derived: sum of 3 quarters · filed 2026-06-11 | $288.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-07-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $115.00K derived: sum of 2 quarters · filed 2026-06-11 | $200.00K derived: sum of 3 quarters · filed 2026-06-11 | $275.00K 10-K · filed 2025-10-29 |
| 2025-04-30 | $61.00K 10-Q · filed 2026-06-11 | $146.00K derived: sum of 2 quarters · filed 2026-06-11 | $221.00K 10-Q · filed 2026-06-11 | $285.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-01-31 | $85.00K 10-Q · filed 2026-03-16 | $155.00K 10-Q · filed 2026-03-16 | $224.00K derived: sum of 3 quarters · filed 2026-03-16 | $304.00K derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-10-31 | $70.00K 10-Q · filed 2025-12-12 | $139.00K derived: sum of 2 quarters · filed 2025-12-12 | $219.00K derived: sum of 3 quarters · filed 2025-12-12 | $288.00K derived: sum of 4 quarters · filed 2025-12-12 |
| 2024-07-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $149.00K derived: sum of 2 quarters · filed 2025-10-29 | $218.00K derived: sum of 3 quarters · filed 2025-10-29 | $296.00K 10-K · filed 2025-10-29 |
| 2024-04-30 | $80.00K 10-Q · filed 2025-06-11 | $149.00K derived: sum of 2 quarters · filed 2025-06-11 | $227.00K 10-Q · filed 2025-06-11 | $452.00K derived: sum of 4 quarters · filed 2025-06-11 |
| 2024-01-31 | $69.00K 10-Q · filed 2025-03-14 | $147.00K 10-Q · filed 2025-03-14 | $372.00K derived: sum of 3 quarters · filed 2025-03-14 | $392.00K derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-10-31 | $78.00K 10-Q · filed 2024-12-11 | $303.00K derived: sum of 2 quarters · filed 2024-12-20 | $323.00K derived: sum of 3 quarters · filed 2024-12-20 | $343.00K derived: sum of 4 quarters · filed 2024-12-20 |
| 2023-07-31 | $225.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $245.00K derived: sum of 2 quarters · filed 2024-12-20 | $265.00K derived: sum of 3 quarters · filed 2024-12-20 | $313.00K 10-K/A · filed 2024-12-20 |
| 2023-04-30 | $20.00K 10-Q · filed 2024-06-14 | $40.00K derived: sum of 2 quarters · filed 2024-06-14 | $88.00K 10-Q · filed 2024-06-14 | |
| 2023-01-31 | $20.00K 10-Q · filed 2024-03-14 | $88.00K 10-Q · filed 2024-03-14 | ||
| 2022-07-31 | $343.00K 10-K · filed 2023-10-30 | |||
| 2021-04-30 | $360.00K 10-Q · filed 2021-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |